Literature DB >> 9328115

Characteristics of asymptomatic secondary immune responses to measles virus in late convalescent donors.

S Huiss1, B Damien, F Schneider, C P Muller.   

Abstract

Among 44 fully protected, late convalescent adults re-exposed to measles, four developed an asymptomatic secondary immune response (SIR) with a significant increase in measles virus (MV)-specific IgG and low IgM. The boosted antibodies were mainly of the IgG1 subclass and reacted with the nucleoprotein and the haemagglutinin protein. About 30 weeks after re-exposure, antibody levels had decreased by 35-50%, suggesting that the booster effect may only be transient. SIR was only found in individuals with a pre-exposure IgG level below a well defined threshold. Antibody levels above this threshold fully protected against SIR. SIR seems to be an 'all or none response' where the magnitude of increase in specific IgG is independent of pre-exposure antibody levels as long as these are below the above threshold. In combination with pre-exposure neutralizing and haemagglutination inhibiting titres, a threshold was defined below which SIR is likely to occur. This may be useful to predict susceptibility to SIR in a given population, since individuals undergoing clinically inapparent SIR are among seropositive subjects, the most likely candidates to support transmission of virus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9328115      PMCID: PMC1904781          DOI: 10.1046/j.1365-2249.1997.00137.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  5 in total

1.  Healthcare Workers and Post-Elimination Era Measles: Lessons on Acquisition and Exposure Prevention.

Authors:  Shruti K Gohil; Sandra Okubo; Stephen Klish; Linda Dickey; Susan S Huang; Matthew Zahn
Journal:  Clin Infect Dis       Date:  2015-09-09       Impact factor: 9.079

2.  Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.

Authors:  F Bouche; W Ammerlaan; F Berthet; S Houard; F Schneider; C P Muller
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

3.  Cross-sectional surveys of measles antibodies in the Jiangsu Province of China from 2008 to 2010: the effect of high coverage with two doses of measles vaccine among children.

Authors:  Yuanbao Liu; Peishan Lu; Ying Hu; Zhiguo Wang; Xiuying Deng; Fubao Ma; Hong Tao; Chengmei Jia; Xiaoyan Ding; Haitao Yang; Pei Liu; Jie Min
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

4.  Measles outbreak in a community with very low vaccine coverage, the Netherlands.

Authors:  S van den Hof; C M Meffre; M A Conyn-van Spaendonck; F Woonink; H E de Melker; R S van Binnendijk
Journal:  Emerg Infect Dis       Date:  2001       Impact factor: 6.883

5.  Evaluation of hemagglutinin protein-specific immunoglobulin M for diagnosis of measles by an enzyme-linked immunosorbent assay based on recombinant protein produced in a high-efficiency mammalian expression system.

Authors:  F B Bouche; N H Brons; S Houard; F Schneider; C P Muller
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.